Magnetic Resonance Imaging in Prostate Cancer Screening

Article Properties
  • Language
    English
  • Publication Date
    2024/04/05
  • Journal
  • Indian UGC (journal)
  • Refrences
    49
  • Tamás Fazekas Comprehensive Cancer Center, Department of Urology, Medical University of Vienna, Vienna, AustriaDepartment of Urology, Semmelweis University, Budapest, HungaryCentre for Translational Medicine, Semmelweis University, Budapest, Hungary
  • Sung Ryul Shim Department of Biomedical Informatics, College of Medicine, Konyang University, Daejeon, Republic of Korea
  • Giuseppe Basile Unit of Urology, Urological Research Institute, Division of Oncology, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
  • Michael Baboudjian Department of Urology, Assistance Publique des Hôpitaux de Marseille, North Academic Hospital, Marseille, France
  • Tamás Kói Centre for Translational Medicine, Semmelweis University, Budapest, HungaryInstitute of Mathematics, Department of Stochastics, Budapest University of Technology and Economics, Budapest, Hungary
  • Mikolaj Przydacz Department of Urology, Jagiellonian University Medical College, Krakow, Poland
  • Mohammad Abufaraj Division of Urology, Department of Special Surgery, Jordan University Hospital, The University of Jordan, Amman, JordanThe National Center for Diabetes, Endocrinology and Genetics, The University of Jordan, Amman, Jordan
  • Guillaume Ploussard Department of Urology, La Croix du Sud Hospital, Quint Fonsegrives, France
  • Veeru Kasivisvanathan Division of Surgery and Interventional Science, University College London, London, England
  • Juan Gómez Rivas Department of Urology, Hospital Universitario La Paz, Madrid, Spain
  • Giorgio Gandaglia Unit of Urology, Urological Research Institute, Division of Oncology, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
  • Tibor Szarvas Department of Urology, Semmelweis University, Budapest, HungaryDepartment of Urology, University of Duisburg-Essen and German Cancer Consortium–University Hospital Essen, Essen, Germany
  • Ivo G. Schoots Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, the NetherlandsDepartment of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands
  • Roderick C. N. van den Bergh Department of Urology, St Antonius Hospital, Utrecht, the NetherlandsDepartment of Urology, Erasmus MC, Rotterdam, the Netherlands
  • Michael S. Leapman Department of Urology, Yale School of Medicine, New Haven, Connecticut
  • Péter Nyirády Department of Urology, Semmelweis University, Budapest, HungaryCentre for Translational Medicine, Semmelweis University, Budapest, Hungary
  • Shahrokh F. Shariat Comprehensive Cancer Center, Department of Urology, Medical University of Vienna, Vienna, AustriaHourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, JordanDepartment of Urology, University of Texas Southwestern Medical Center, DallasDepartment of Urology, Second Faculty of Medicine, Charles University, Prague, Czech RepublicDepartment of Urology, Weill Cornell Medical College, New York, New York
  • Pawel Rajwa Comprehensive Cancer Center, Department of Urology, Medical University of Vienna, Vienna, AustriaDepartment of Urology, Medical University of Silesia, Zabrze, Poland
Abstract
Cite
Fazekas, Tamás, et al. “Magnetic Resonance Imaging in Prostate Cancer Screening”. JAMA Oncology, 2024, https://doi.org/10.1001/jamaoncol.2024.0734.
Fazekas, T., Shim, S. R., Basile, G., Baboudjian, M., Kói, T., Przydacz, M., Abufaraj, M., Ploussard, G., Kasivisvanathan, V., Rivas, J. G., Gandaglia, G., Szarvas, T., Schoots, I. G., van den Bergh, R. C. N., Leapman, M. S., Nyirády, P., Shariat, S. F., & Rajwa, P. (2024). Magnetic Resonance Imaging in Prostate Cancer Screening. JAMA Oncology. https://doi.org/10.1001/jamaoncol.2024.0734
Fazekas, Tamás, Sung Ryul Shim, Giuseppe Basile, Michael Baboudjian, Tamás Kói, Mikolaj Przydacz, Mohammad Abufaraj, et al. “Magnetic Resonance Imaging in Prostate Cancer Screening”. JAMA Oncology, 2024. https://doi.org/10.1001/jamaoncol.2024.0734.
Fazekas T, Shim SR, Basile G, Baboudjian M, Kói T, Przydacz M, et al. Magnetic Resonance Imaging in Prostate Cancer Screening. JAMA Oncology. 2024;.
Journal Categories
Medicine
Internal medicine
Neoplasms
Tumors
Oncology
Including cancer and carcinogens
Medicine
Medicine (General)
Refrences
Title Journal Journal Categories Citations Publication Date
Adherence to a risk-adapted screening strategy for prostate cancer: first results of the PROBASE trial. International Journal of Cancer
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General)
2023
The oncologic risk of magnetic resonance imaging-targeted and systematic cores in patients treated with radical prostatectomy. Cancer
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General)
2023
A Detailed Evaluation of the Effect of Prostate-specific Antigen–based Screening on Morbidity and Mortality of Prostate Cancer: 21-year Follow-up Results of the Rotterdam Section of the European Randomised Study of Screening for Prostate Cancer European Urology
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology
  • Medicine: Medicine (General)
14 2023
Environmental Impact of Prostate Magnetic Resonance Imaging and Transrectal Ultrasound Guided Prostate Biopsy European Urology
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology
  • Medicine: Medicine (General)
9 2023
An Evaluation of Screening Pathways Using a Combination of Magnetic Resonance Imaging and Prostate-specific Antigen: Results from the IP1-PROSTAGRAM Study European Urology Oncology 6 2023